| 000 | 01898 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515144201.0 | ||
| 264 | 0 | _c20090107 | |
| 008 | 200901s 0 0 eng d | ||
| 022 | _a1477-7819 | ||
| 024 | 7 |
_a10.1186/1477-7819-6-114 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeneses-García, Abelardo | |
| 245 | 0 | 0 |
_aExpression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas. _h[electronic resource] |
| 260 |
_bWorld journal of surgical oncology _cOct 2008 |
||
| 300 |
_a114 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 | _aBiopsy, Needle |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aLymphoma, Extranodal NK-T-Cell _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xgenetics |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xgenetics |
| 650 | 0 | 4 |
_aMatrix Metalloproteinases _xgenetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNose Neoplasms _xgenetics |
| 650 | 0 | 4 | _aProbability |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xgenetics |
| 650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-2 _xgenetics |
| 700 | 1 | _aBetancourt, Alejandro Mohar | |
| 700 | 1 | _aAbarca, Jorge Herrera | |
| 700 | 1 | _aMontes, Adriana Becerril | |
| 700 | 1 | _aRoa, Lourdes Suarez | |
| 700 | 1 | _aRuíz-Godoy, Luz | |
| 773 | 0 |
_tWorld journal of surgical oncology _gvol. 6 _gp. 114 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1477-7819-6-114 _zAvailable from publisher's website |
| 999 |
_c18416867 _d18416867 |
||